Important events during the first quarter
- Underlying sales were overall as expected, despite Q1 coming in 12% below Q1 LY (11% adjusted for currency effects) to
SEK 152 m (172). The reduction compared to LY is primarily due to positive one-time effects from delayed deliveries in theAmericas as a result of a severe snowstorm at the end of 2022. Additionally, APAC was affected by timing shifts in orders during the quarter. - The EBITDA margin amounted to 15% (28). Adjusted for the above-mentioned snowstorm the comparison year margin is 23%.
-
A new study showing synergistic benefits in
Probi's and Clasado's joint synbiotic immune health concept was published in theInternational Journal of Nutritional Sciences . Probi was selected as a finalist in the annual NutraIngredients Awards for its pioneeringProbi ®Sensia concept, improving cognition, mood and sleep.Probi strengthened its brand position in the Nordic regions, by expanding the B2C operations intoDenmark through a partnership with Matas.Probi attained silver status fromEcoVadis , for its performance in sustainability.
CEO Comments: Steady Progress in a Transitional Year
The start of 2024 has been characterized by a whirlwind of activities and events, largely fueled by our strategic revamp introduced in the later part of 2023. Our sales were relatively stable and in line with our expectations for this transitional year, looking beyond some disadvantageous comparatives in
Commercially we have achieved several notable highlights. In March, our team in
In terms of scientific advancements, our collaboration with Clasado has progressed well. The R&D teams involved in our partnership have worked closely together to add further evidence of the synergistic benefits of combining our products. At the end of the quarter, we were proud to announce the publication of our findings in the
As we progress into 2024, I remain firmly committed to cultivating a robust and adaptable organization united by a common purpose. Our primary focus is on establishing the optimal conditions for commercial success and sustainable profitable growth, in accordance with our outlined goals for 2024-2028. We are already witnessing positive developments from our strategic and operational revamps. As previously communicated, 2024 will be a transitional year with modest expectations on increased growth and profitability. While the financial outcomes are not expected in the immediate future, I am, however, confident that we are heading in the right direction.
CEO
Invitation to teleconference
The presentation is available at www.probi.com and www.financialhearings.com.
Contact
Per Lindblad, CFO, Tel: +46 (0)46 286 89 41, E-mail: per.lindblad@probi.com
This information is information that
https://news.cision.com/probi/r/q1-2024--steady-progress-in-a-transitional-year,c3965590
https://mb.cision.com/Main/1556/3965590/2750420.pdf
(c) 2024 Cision. All rights reserved., source